Access Statistics for Amy Finkelstein

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Taste of Their Own Medicine: Guideline Adherence and Access to Expertise 0 0 0 21 1 1 3 34
Adverse Selection in Insurance Markets: Policyholder Evidence from the U.K. Annuity Market 0 0 0 451 0 1 5 1,678
Approaches to Estimating the Health State Dependence of the Utility Function 0 0 0 73 1 1 2 182
Approaches to Estimating the Health State Dependence of the Utility Function 0 0 1 34 0 0 2 108
Beyond Statistics: The Economic Content of Risk Scores 0 1 1 30 1 2 2 59
Beyond Testing: Empirical Models of Insurance Markets 0 0 0 91 0 0 2 263
Beyond Testing: Empirical Models of Insurance Markets 0 0 0 15 0 0 2 95
Bunching at the Kink: Implications for Spending Responses to Health Insurance Contracts 0 0 0 38 1 2 3 82
Did Medicare Induce Pharmaceutical Innovation? 0 0 0 140 0 2 5 658
Did Medicare Induce Pharmaceutical Innovation? 0 0 0 4 0 1 4 149
Dynamic Inefficiencies in Insurance Markets: Evidence from long-term care insurance 0 0 1 111 0 0 5 504
E-ZTax: Tax Salience and Tax Rates 0 0 0 56 1 2 3 287
Empirical Analyses of Selection and Welfare in Insurance Markets: A Self-Indulgent Survey 0 0 2 6 0 0 11 24
Estimating Welfare in Insurance Markets Using Variation in Prices 0 0 0 62 0 0 1 263
Estimating Welfare in Insurance Markets Using Variation in Prices 0 0 1 23 0 0 6 137
Estimating Welfare in Insurance Markets Using Variation in Prices 0 0 1 14 1 2 3 109
Geographic Variation in Healthcare Utilization: The Role of Physicians 0 0 3 34 0 1 15 44
Health Policy and Technological Change: Evidence from the Vaccine Industry 0 0 0 133 0 1 1 584
Healthcare Exceptionalism? Performance and Allocation in the U.S. Healthcare Sector 0 0 0 36 0 2 4 96
Healthcare Exceptionalism? Productivity and Allocation in the U.S. Healthcare Sector 0 0 0 37 2 3 4 184
Healthcare Spending and Utilization in Public and Private Medicare 0 0 1 59 1 2 3 87
Heterogeneity in Damages from A Pandemic 0 0 0 16 0 2 3 23
How General Are Risk Preferences? Choices Under Uncertainty in Different Domains 0 0 0 41 1 2 4 243
How general are risk preferences? Choices under uncertainty in different domains 0 0 0 52 0 0 2 218
In Praise of Moderation: Suggestions for the Scope and Use of Pre-Analysis Plans for RCTs in Economics 0 0 5 69 0 3 15 205
Income and Health Spending: Evidence from Oil Price Shocks 0 0 0 200 0 1 8 553
Income and Health Spending: Evidence from Oil Price Shocks 0 0 0 88 0 3 6 353
Input and Technology Choices in Regulated Industries: Evidence From the Health Care Sector 0 0 1 120 0 0 10 590
Insuring Long Term Care In the US 0 0 0 80 0 0 1 206
Is American Pet Health Care (Also) Uniquely Inefficient? 0 0 1 21 1 1 4 76
Lives vs. Livelihoods: The Impact of the Great Recession on Mortality and Welfare 0 1 25 27 2 3 57 61
Long-Term Care Hospitals: A Case Study in Waste 1 2 3 31 4 17 32 94
Market Design in Regulated Health Insurance Markets: Risk Adjustment vs. Subsidies 0 0 7 7 0 0 19 19
Medicaid Crowd-Out of Private Long-Term Care Insurance Demand: Evidence from the Health and Retirement Survey 0 0 0 98 0 1 2 573
Minimum Standards and Insurance Regulation: Evidence from the Medigap Market 0 0 0 74 0 1 2 437
Moral Hazard in Health Insurance: How Important Is Forward Looking Behavior? 0 0 0 48 1 2 4 296
Moral Hazard in Health Insurance: What We Know and How We Know It 0 1 1 52 1 3 6 157
Moral hazard in health insurance: How important is forward looking behavior? 0 0 0 32 0 0 1 238
Out of the Woodwork: Enrollment Spillovers in the Oregon Health Insurance Experiment 0 0 0 7 0 1 1 23
Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments 0 0 0 30 1 1 2 57
Paying on the margin for medical care: Evidence from breast cancer treatments 0 0 0 22 1 2 4 44
Place-Based Drivers of Mortality: Evidence from Migration 0 0 0 55 2 4 7 107
Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance 0 0 0 137 0 0 1 411
Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance 0 0 1 11 0 0 3 105
Private Information and its Effect on Market Equilibrium: New Evidence from Long-Term Care Insurance 0 0 0 155 2 4 6 722
Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D 0 0 0 28 0 1 1 102
Producing Health: Measuring Value Added of Nursing Homes 0 0 2 24 0 0 12 45
Provider Incentives and Healthcare Costs: Evidence from Long-Term Care Hospitals 0 0 0 37 0 0 0 68
Redistribution by Insurance Market Regulation: Analyzing a Ban on Gender-Based Retirement Annuities 0 0 0 44 0 0 2 379
Screening and Selection: The Case of Mammograms 0 1 1 11 0 2 2 61
Selection Effects in the Market for Individual Annuities: New Evidence from the United Kingdom 0 0 0 203 0 1 3 1,506
Selection in Insurance Markets: Theory and Empirics in Pictures 0 0 0 30 0 1 2 178
Selection in Insurance Markets: Theory and Emprirics in Pictures 0 0 0 24 0 0 3 144
Selection on Moral Hazard in Health Insurance 0 0 1 62 0 1 5 264
Selection on Moral Hazard in Health Insurance 0 0 0 67 0 1 4 190
Social Insurance: Connecting Theory to Data 0 2 3 279 0 4 15 801
Sources of Geographic Variation in Health Care: Evidence from Patient Migration 1 2 3 91 3 5 10 212
Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts 0 0 1 60 0 1 5 101
Supply or Demand: Why is the Market for Long-Term Care Insurance So Small? 0 0 0 288 0 0 3 1,268
Take-up and Targeting: Experimental Evidence from SNAP 0 0 2 19 0 0 10 76
Targeting Precision Medicine: Evidence from Prenatal Screening 0 0 1 18 1 2 3 13
Testing for Asymmetric Information Using 'Unused Observables' in Insurance Markets: Evidence from the U.K. Annuity Market 0 0 1 131 0 1 6 551
The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare 0 1 3 174 0 4 12 992
The Challenges of Universal Health Insurance in Developing Countries: Evidence from a Large-scale Randomized Experiment in Indonesia 0 0 0 139 0 0 0 197
The Economic Consequences of Hospital Admissions 0 0 0 62 1 2 5 146
The Effect of Medicaid on Crime: Evidence from the Oregon Health Insurance Experiment 12 13 13 13 0 4 4 4
The Health Wedge and Labor Market Inequality 0 0 0 19 0 0 3 22
The IO of Selection Markets 0 0 0 39 0 0 1 123
The Impact of Medicaid Expansion on Voter Participation: Evidence from the Oregon Health Insurance Experiment 0 0 0 60 0 1 1 60
The Impact of Medicaid on Labor Force Activity and Program Participation: Evidence from the Oregon Health Insurance Experiment 0 0 0 57 1 1 5 197
The Interaction of Partial Public Insurance Programs and Residual Private Insurance Markets: Evidence from the U.S. Medicare Program 0 0 0 103 1 1 2 514
The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market 0 0 2 168 0 0 9 756
The Oregon Health Insurance Experiment: Evidence from the First Year 0 0 1 65 1 2 6 249
The Oregon Health Insurance Experiment: Evidence from the First Year 1 1 3 152 2 3 18 607
The RAND Health Insurance Experiment, Three Decades Later 0 0 2 28 1 1 7 180
The RAND Health Insurance Experiment, Three Decades Later 0 0 0 83 1 2 6 375
The Response of Drug Expenditures to Non-Linear Contract Design: Evidence from Medicare Part D 0 0 0 12 2 2 3 84
The Value of Medicaid: Interpreting Results from the Oregon Health Insurance Experiment 0 0 1 75 0 0 2 127
The Welfare Cost of Asymmetric Information: Evidence from the U.K. Annuity Market 0 0 0 81 1 1 2 399
Voluntary Regulation: Evidence from Medicare Payment Reform 0 0 0 11 0 1 3 43
Welfare Analysis Meets Causal Inference 1 1 2 16 2 4 7 58
What Did Medicare Do (And Was It Worth It)? 0 0 0 140 2 2 5 694
What Does (Formal) Health Insurance Do, and For Whom? 0 0 0 48 0 1 3 59
What Drives Risky Prescription Opioid Use? Evidence from Migration 0 0 1 55 2 3 10 135
What Good Is Wealth Without Health? The Effect of Health on the Marginal Utility of Consumption 0 0 0 88 0 1 12 363
What Good Is Wealth without Health? The Effect of Health on the Marginal Utility of Consumption 0 0 0 98 1 1 1 299
When Can Partial Public Insurance Produce Pareto Improvements? 0 0 0 112 0 0 0 468
Why is End-of-Life Spending So High? Evidence from Cancer Patients 0 0 0 17 0 0 3 45
Total Working Papers 16 26 98 6,272 47 131 502 24,593


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Adverse Selection in Insurance Markets: Policyholder Evidence from the U.K. Annuity Market 0 1 5 514 0 2 24 1,818
Approaches to Estimating the Health State Dependence of the Utility Function 0 0 1 71 0 0 4 243
Beyond Testing: Empirical Models of Insurance Markets 0 0 2 54 2 4 11 410
Did Medicare Induce Pharmaceutical Innovation? 0 0 1 63 0 3 6 471
Dynamic Inefficiencies in Insurance Markets: Evidence from Long-Term Care Insurance 0 0 1 53 0 1 7 335
How General Are Risk Preferences? Choices under Uncertainty in Different Domains 0 0 0 50 0 4 4 277
Income and Health Spending: Evidence from Oil Price Shocks 0 1 3 150 1 4 21 667
Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector 1 1 5 163 3 4 15 802
Insuring Long-Term Care in the United States 1 1 2 58 4 4 13 265
Minimum standards, insurance regulation and adverse selection: evidence from the Medigap market 0 0 0 65 1 2 3 210
Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market 0 0 1 287 0 2 9 1,029
Optimal Mandates and the Welfare Cost of Asymmetric Information: Evidence From the U.K. Annuity Market 0 0 0 21 0 0 1 146
Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance 0 0 1 114 0 1 4 398
Redistribution by insurance market regulation: Analyzing a ban on gender-based retirement annuities 0 0 2 79 0 0 8 428
Selection Effects in the United Kingdom Individual Annuities Market 0 0 0 177 2 3 6 690
Selection in Insurance Markets: Theory and Empirics in Pictures 1 1 2 60 5 7 13 263
Selection on Moral Hazard in Health Insurance 0 0 0 152 1 5 12 711
Testing for Asymmetric Information Using “Unused Observables” in Insurance Markets: Evidence from the U.K. Annuity Market 0 0 0 32 0 0 3 148
The Impact of Medicaid on Labor Market Activity and Program Participation: Evidence from the Oregon Health Insurance Experiment 0 1 2 43 1 4 6 249
The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market 0 0 0 151 0 2 9 663
The Oregon Health Insurance Experiment: Evidence from the First Year 0 1 6 307 3 10 36 1,389
The RAND Health Insurance Experiment, Three Decades Later 0 1 3 110 2 6 16 582
The effect of tax subsidies to employer-provided supplementary health insurance: evidence from Canada 0 1 1 113 0 4 5 321
The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program 0 0 0 30 1 1 4 162
WHAT GOOD IS WEALTH WITHOUT HEALTH? THE EFFECT OF HEALTH ON THE MARGINAL UTILITY OF CONSUMPTION 0 0 5 90 0 5 17 473
What did Medicare do? The initial impact of Medicare on mortality and out of pocket medical spending 1 1 2 303 5 9 25 1,027
Why is the market for long-term care insurance so small? 0 1 3 147 2 4 13 558
Total Journal Articles 4 11 48 3,457 33 91 295 14,735


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Bunching at the Kink: Implications for Spending Responses to Health Insurance Contracts 0 0 0 0 0 1 4 48
Comment on "Mind the Gap! Consumer Perceptions and Choices of Medicare Part D Prescription Drug Plans" 0 0 0 8 0 1 1 57
Comment on "The Demand for Medicare Part D Prescription Drug Coverage: Evidence from Four Waves of the Retirement Perspectives Survey" 0 0 0 4 0 0 1 35
Medicaid Crowd-Out of Private Long-Term Care Insurance Demand: Evidence from the Health and Retirement Survey 0 0 1 24 2 2 4 156
Why Is the Market or Long-term Care Insurance So Small? 0 0 0 0 3 3 3 157
Total Chapters 0 0 1 36 5 7 13 453


Statistics updated 2025-03-03